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ALTERATIONS IN URINARY N1 -ACETYLSPERHIDINE EXCRETION IN
RESPONSE TO CASTRATION AND TESTOSTERONE REPLACEMENT
Abstract of Thesis
Castration and testosterone replacement therapy served as a
model to assess anabolic activity in the rat. The present
study was undertaken to examine more closely whether changes
in cellular anabolic activity are reflected in subsequent
alterations of urinary N -acetylspermidine excretion.
A sensitive fluorometric assay was employed which utilized
the dansylation reaction . The dansylated derivatives were
quantitated by normal phase high pressure liquid chromatography. This assay system exhibited a range of linearity
from 0.1 to 10 nanomoles which encompassed the physiological
variability observed during analysis of urinary Nl-acetyl spermidine.
The normal level of N1 -acetylspermidine excreted in rat
urine was found to be 803.1 ± 208.9 nanomoles per day (mean
± 1 S.D.).
In addition both N8-acetylspermidine and acetyl putrescine were detected, but not quantitated.
Due to the high variability of the polyamine excretion, no
statistically significant difference could be detected
between castrated animals, castrated animals receiving
testosterone, and sham operated animals. Still some trends
were noted which were in agreement with the hypothesis that
urinary excretion of polyamines may reflect the anabolic
state of the animal. Further studies will be required to
determine whether or not a correlation between anabolic
activity and urinary excretion of acetylated polyamines
exists.
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INTRODUCTION
The polyamines putrescine, spermidine, and spermine are
highly cationic compounds found in animals, plants, and
bacteria .

The pathway for the biosynthesis of polyamines as

illustrated in Figure 1 occurs in all animals and in many
microorganisms (1, 2).

Ornithine, a component of the urea

cycle, serves as the precursor for putrescine through a
reaction catalyzed by ornithine decarboxylase (ODC) .

In

most living cells, the activity of ornithine decarboxylase
is normally the lowest of the enzymes involved in the synthesis of polyamines.

Therefore ODC is considered to be the

rate limiting enzyme in polyamine biosynthesis.

Spermidine

can be formed from putrescine by the enzyme spermidine synthase through the addition of a propylamine moiety derived
from S-adenosylmethionine.

Spermidine may in turn be con-

verted to spermine by the enzyme spermine synthase.
Polyamines are rather stable intracellular components
with a half-life of 4-5 days (3) .

Since polyamine turnover

is slow, intrace llu l ar levels are probably controlled by
metabolizing enzymes.

These polyamine metabolizing enzymes
1

2

The Biosynthesis of Polyamines

Figure 1
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include oxidizing enzymes such as diamine oxidase, polyamine
oxidase and the acetylating enzymes (4, 5).
A.

Function of Polyamines
Host information on the biological effects of polyamines

has been obtained from: in Vitro experimentation .

Therefore

generalizations from in vitro work as to the physiological
role of polyamines should be done with caution.

In general,

polyamines are now regarded as factors necessary for normal
growth in most living cells (6).

In isolated systems they

have been shown to modify many aspects of . pro.bein synthes..is,
both at the transcriptional and translational levels.

In

response to erowth stimuli, polyamine levels, nucleic acid
synthesis, and protein synthesis increase strikingly, but
whether the increase in polyamines is an essential component
of the anabolic response is still unknown (7) .
Functionally, polyamines are organic cations.

However,

unlike inorganic cations such as Ca++ and Mg++ which must be
transported to cells, polyamines are cations which can be
synthesized by the cells at levels which may reflect cellular
need.

Polyamine synthesis is regulated by ODC which, due to

its extremely short half-life of 11 minutes (8) , can undergo
rapid changes in intracellular levels; however, polyamine
levels in cells change much more slowly.
B. · Ornithine Decarboxylase
Ornithine decarboxylase activity has been shown to in crease markedly in a variety of rapidly growing tissues.
ODC activity increases during embryonic growth, compensatory
growth such as in liver regeneration, anabolic hormone
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stimulation, renal hypertrophy, and neoplastic growth (1, 7,
9).

After partial hepatectomy, the level of ODC activity in

the rapidly regenerating rat liver increases almost 25-fold,
compared to normal liver (10).

The elevation of ODC activity

can be seen as early as one hour after surgery, and reaches
a peak after 12 - 16 hours.

Hypophysectomy abolished the

early enhancement of ODC in the above response .

This effect

could be reversed by the administration of growth hormone.
Other hormones such as androgens and gonadotrophins can also
induce ODC activity in various organ systems (7).

Therefore,

it is clear that ODC activity can be modified to a certain
extent by the endocrine system.
C. · Endocrine Control of Polyamines
The pattern of ornithine decarboxylase induction is almost identical for both peptide and steroid hormones.

There-

fore even though these hormones act at different receptor
sites, there may be some common component in their induction
of ODC.

Since virtually all hormones have been shown to in-

crease ODC levels in their target tissues, Maudsley (1)
generalized that stimulation of ODC activity may be a biolo gical marker for the anabolic response of a cell .
In rapidly growing tissues, ODC levels are elevated as
are intracellular polyamines and RNA levels,

So perhaps not

only can an increase in ODC levels be considered as a cellular response to an anabolic stimulus, but also the subsequent increase in intracellular polyamine levels.

5
Anabolic hormones stimulate protein synthesis in various
organs; thus they enhance body weight and produce a positive
nitrogen balance.

Androgenic stero i ds such as testosterone,

have an additional growth promoting effect on the reproductive organs (11) .

Consequently many endocrine studies have

dealt with the effeGts of androgens on cellular levels and
on the synthesis of polyamines in male accessory sex organs.
Castration leads to a rapid involution of the ventral
prostate in rats with a corresponding decrease in ODC
activity and intracellular polyamine levels; testosterone replacement therapy, in turn, will increase these parameters
(12, 13) .
Fueller and coworkers (14) criticized the use of the
ventral prostate as a model for anabolic response since this
gland also secretes polyamines into seminal fluid which is
not a characteristic of -other tissues undergoing increased
cellular proliferation.

Takysi et al (15) have reported that

ODC and polyamine levels in rat seminal vesicles directly reflect testosterone levels, and can serve as a measure of
anabolic activity.
Much of the work which is concerned with the endocrine
control of polyamines has dealt only with tissue levels and
little research has been done on urinary polyamines in res ponse to various physiological stimuli.

Rosengren and co-

workers (16 - 18) have focused on testosterone's effect on
the synthesis, tissue levels, and urinary excretion of polyamines in mice.

One of their goals was to relate intra-
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cellular polyamine levels to the amount of polyamines ex creted in the urine .
In 1975 Henningsen and Rosengren (16) showed that testosterone may play an important role in the regulation of
ODC levels in mouse kidney.

In newborn mice, the renal ODC

activity was similar in males and females, but three weeks
after birth, ODC activity increased sharply in the male
kidney while ODC activity remained low in females.

In ad-

dition, castration of male mice decreased renal ODC activity
markedly as well as kidney weight when compared to sham controls.

These results could be reversed by testosterone

therapy.
In 1978 Henningsen et al (17) looked more closely at the
changes in the mouse kidney evoked by castration and testosterone replacement .

ODC levels increased more than 1000-

fold after testosterone was administered to the castrated
rats.

Intracellular levels of putrescine, spermidine, and

spermine also increased strikingly.

With testosterone re-

placement, renal protein and RNA levels increased in parallel
with the polyamine increase.
Henningsen and Rosengren (19) measured the effect of
nandrolene, an anabolic steroid with low androgenic activity,
on polyamine metabolism in the mouse.

After nandrolene ad-

ministration, renal putrescine, spermidine , and spermine
levels increased markedly in the castrated animals.

In ad-

dition urinary excretion of putrescine and spermidine in - .
creased significantly compared to controls.
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In pregnant rats (20), ovarian putrescine formation increased sharply during pregnancy.

Putrescine and spermidine

urinary excretion paralleled this increase in polyamine production (21).

Therefore, in the latter two studies an in-

crease in intracellular polyamines can apparently be correlated with an enhancement of urinary polyamine excretion.
D.

Po lyam:ines and Cancer
Since polyamines have been implicated in the ,c ellular

growth process, much work concerning polyamines has attempted
to define their role in neoplastic growth.

In 1971, Russell

et al (22) reported a high level of polyamines in the urine
of cancer patients compared to normal patients.

In leukemia

patients, the amount of spermidine has been reported to increase considerably relative to control patients (23).
However, increased serum or urinary polyamine levels are not
consistently found with all cancers.

Therefore, Janne (7)

states that, in general, polyamine determinations may only
play a minor role in early diagnosis of cancer .

Russell and

Russell (24) observed that the concentration of polyamines
in urine increased in cancer patients in response to success ful chemotherapy perhaps due to release during tumor cell
death (25).

Consequently polyamine measurements were sug-

gested by these authors as useful in monitoring the success
of anticancer therapy.
Most researchers who have studied urinary polyamine
levels have used acid hydrolysis of urine samples prior to
analysis in order to free polyamines from their acid-labile
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conj ~uga'Ded

foms. This has allowed measurement of total

urinary polyamine levels and simplified analysis; however, it
has resulted in a general lack of data regarding conjugated
polyamines in the urine.

Recently a few studies have quan- .

titated polyamine conjugates in the urine to determine their
usefulness as indicators of cancer.
E. · Acetylated Polyamihes in Urine
In 1967 Siimes (26) observed the fate of exogenously administered polyamines in rats.

He injected radiolabeled

spermidine and -found that about 25% of the radioactivity was
excreted in the urine over an eight day period.

This radio-

active fraction in the urine contained unidentified compounds
which yielded polyamines after strong acid hydrolysis.
Nakajima and co-workers (27) identified one compound as N 1 ~
acetylspermidine, and Nota et al (28) isolated N8 -acetylspermidine as well from rat urine.
Tsuji et al (23) has looked more closely at the specific
polyamines excreted by normal and cancer patients. These
·
· t ors ~so
· 1 a t e d N1 - and N8 - ace t y 1 sperm~· d ~ne
·
· h uman
~nvest~ga
~n
urine and reported that the amount of the N-acetylspermidines
in normal urine was 3-4 times that of the free spermidine in
normal urine.
Abdel-Monem and Ohno (29) developed a specific and sensitive assay to measure acetylated polyamine levels in urine
by high pressure liquid chromatography (HPLC).

They detected

in the urine of non-cancerous patients acetylputrescine,
acetylcadaverine, and two isomers of N-acetylspermidine, as
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well as free polyamines (30 - 32) .

In addition Abdel-Monem 1 s

group (33) observed that perhaps it is not the amount of
acetylated polyamines excreted which is a good ma~ker for
cancer, but the N1 -acetylspermidine/N 8 -acetylspermidine
ratio in the urine.

They also concluded that polyamines

were excreted in the urine mainly in the conjugated form.
Seiler and Knodgen (34) achieved similar results utilizing thin layer chromatography (TLC).

Virtually all conjugat -

ed putrescine and spermidine were in the acetylated form in
urine with less than 10% of urinary putrescine and spermidine excreted in the free form.

Therefore acid hydrolysis

may not be appropriate in the analysis of polyamines .
. F . . Synthesis and Metabolism of Acetylated Polyamine
The tissues from which urinary polyamines originate have
not yet been determined nor have the sites of acetylation of
urinary polyamines been elucidated.

However, several tissues

have the capacity to acetylate polyamines .

Seiler and

Al-Therib (35) have described in vitro acetylation of
putrescine to monoacetylputrescine in rat brain, kidney and
liver fractions.

Brain and kidney microsomal preparations

as well as liver and brain nuclear fractions exhibited significant levels of putrescine acetylating activity.
Recently Matsui et al (36) detected substantial putrescine
acetylating activity in liver cytosol fractions in rats
treated with carbon tetrachloride.

In liver homogenates, no

acetylputrescine formation could be detected, therefore
metabolizing enzymes may be present which degrade the
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monoacetylputrescine as rapidly as it is synthesized.
Blankenship and Walle (5) have detected acetylating activity in chromatin fractions of rat liver and kidney.

They

concluded that the polyamines spermidine and spermine can
act as substrates for an acetyl-GoA-dependent N-acetyltransferase enzyme found in the nuclear fractions. Acetylation of spermidine gave rise to two isomers, N1 -acetyl8
spermidine and N8 -acetylspermidine of which N -acetylspermidine was the major in vitro acetylation product.

In addition

this acetylating activity could also be measured in rat kidney
microsomal preparations but not in rat liver microsomes or
the whole homogenate .

These results suggested that there may

be acetylpolyamine metabolizing enzymes responsible for controlling intracellular acetylated polyamine levels.
Work has been undertaken to clarify the nature of the
acetylpolyamine metabolizing enzymes.

Seiler and Eichentopf

(37) looked at the metabolic fate of acetylputrescine.
This compound underwent oxidative deamination in rat brain
homogenates via monoamine oxidase, and this oxidative product
can undergo further metabolic conversion to form gammaamino butyric acid (GABA).

In addition deacetylation of

/

monoacetylputrescine was observed in the rat brain fractions.
Holtta (4) has reported that N1 -acetylspermidine could
be converted to putrescine by oxidative metabolism.
Blankenship (38) has found that the soluble cytosol fraction
of rat liver, kidney, and spleen demonstrated N8 -acetylspermidine deacetylating activity.

N1 -acetylspermidine was
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not significantly deacetylated in this system, but instead
was metabolized to putrescine as observed by Ho1tta (39) .
Blankenship and Walle (40) theorized that the levels of
polyamines can thus be regulated by the acetylation-deacetylation reactions.

Intracellular acetyl.a ted polyamine levels

may reflect the relative balance of activities of the nuclear
N-acetyltransferase enzymes compared to the cytoplasmic
deacetylating and micro·somal polyamine oxidase systems.
This proposed system for regulation of polyamine and acetylpolyamine levels in the cell nucleus would have interesting
ramifications.
Polyamines have been predicted to bind to DNA through a
strong interaction between the cationic amine groups and the
anionic phosphate backbone of the nucleic acids (41).

Thus

the polyamines can stabilize DNA against heat denaturation
(42).

Since polyamine acetylation would neutralize one

cationic charge on the polyamine, there may be a change in
affinity for the DNA.

This alteration of affinity may play

a role in regulating the function of the polyamines relative
to DNA synthesis, protein synthesis, and tissue growth.

It

would seem important to examine the relationship of polyamine
acetylation to changes in tissue growth which may be induced
by a variety of factors including castration and testosterone therapy.
· G.

Statement of Purpose
Polyamines have an enigmatic relationship to cellular

growth.

Most work with anabolic hormones has focused on the
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effects on tissue enzymes and tissue polyamine levels.

How-

ever, researchers have investigated the changes in urinary
polyamine levels in response to anabolic treatment.

Most

studies of urinary polyamines have quantitated the free
levels of polyamines or of total polyamines after acid
hydrolysis.

In human studies, putrescine and spermidine are

primarily excreted in urine in the acetylated form (34). In
rats both N1 - and N8 -acetylspermidine have been identified,
but have not been quantified.

Therefore it would seem import -

ant to eliminate the acid hydrolysis step from the analysis
of urinary polyamines, and measure these compounds in their
native or acetylated form.
In the present study, a simple yet sensitive chromatographic method for measuring urinary N1 -acetylspermidine
has been developed and used to determine normal urinary
values.

The effects of castration and of testosterone replacement therapy on the excretion of N1 -acetylsperrnidine

have also been measured in the present study.

Such data may

prove useful in determining whether or not urinary acetylated
polyamines reflect anabolic activity.

If there is a corre-

lation , urinary assays would be a more practical indicator
of such activity than the direct measurement of tissue
levels.

MATERIALS AND METHODS
A.

Chemicals
Dansyl chloride (5-dimethylaminonaphthalene-1-sulfonyl

chloride), sodium carbonate, and testosterone propionate
were purchased from Sigma Chemical Co .

HPLC grade chloro-

form, isopropanol, methanol, and acetone were obtained
through J . T . Baker Chemical Co.

All other solvents used

were analytical grade. Acetylputrescine, and both unlabeled
and acetyl - 3H- labeled N1 - and N8 -acetylspermidine standards
were synthesized by established procedures (38).
B.

Animals
~ale

adult Wistar rats, 180 - 200 grams in weight were

obtained from Simonsen Laboratories, Inc . , Gilroy, CA.
When urine was not being collected, animals were housed with
members of the same experimental group, and fed standard lab
chow (Simonsen S/L Custom lab diet G 4 . 5) and water ad
libitum.

During urine collection, the rats were housed

separately in Acme hanging rodent metabolism cages which
separated the urine from feces.
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During urine collection,
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animals were given water ad libitum and powdered standard
lab chow mixed with water to form a paste.

The paste de -

creased the amount of particulate matter in the urine when
compared to the powdered diet alone.

Cages were washed every

other day .
C. ·

Castration and Testosterone Replacement Therapy
Castrations were performed on animals under ether

anesthesia.

The testes were excised through a small incision

in the abdominal wall.

The muscle layer was then carefully

sutured together, and the skin closed with wound clips.

For

the sham operations, animals underwent a similar procedure
excep t the testes were not removed.

All animals recovered

from the surgery with no obvious adverse effects .
Four weeks after castration, testosterone propionate
administration was begun with daily subcutaneous injections
of 1 mg testosterone suspended in 0.1 ml peanut oil (U . S.P.)
for 14 days.

Control animals received only vehicle.

A

small concentrated injection volume was utilized since it
would serve as a depot site from which testosterone could
slowly be released into the blood.
D.

Measurement of Kidney Weight
Immediately after the final urine collection, animals

were killed by cervical dislocation, and the kidneys were
surgically removed and trimmed.

The tissue was rinsed with

water, blotted on gauze, and weighed .

15
E.

Urine Collection
Urine was collected over dry ice to prevent bacterial

growth and metabol i sm of the sample .

A 50 ml Erlenmyer

flask was placed inside a styrofoam container filled with
dry ice .

Dry ice was replaced

frozen sample .

o~ce

each day to maintain a

After each 24 hour collection, the urine was

thawed, and the total urinary volume measured.

Aliquots of

no more than 10 ml were transferred to tubes and centrifuged
at 1500 rpm for 20 minutes (Damon/IEC model K centrifuge).
Urine was then transferred to a test tube, sealed with
paraffin, and stored frozen until analyzed.
· F. Analysis of Urine Samples for N1 -Acetylspermidine
The assay procedure was adapted from the methods of
Abdel .. Moneni et al (33) and Seiler and Kno'dgen (Y-3.).
sample was analyzed in duplicate .

Each

Frozen samples were

thawed at room temperature, and 0 . 5 ml aliquots were
di luted with 7.5 ml of 0 . 2 N perchloric acid (PCA) .

Acety-

lated polyamine standards were diluted with PCA giving a
final concentration of 0.2 N PCA.

Aliquots of 0.5 ml of

diluted urine samples and standards were placed in 15 ml
conical centrifugation tubes and saturated with sodium
carbonate giving a final pH of approximately 10.

Three

volumes of dansyl chloride (Dans Cl) in acetone (10 mg/ml,
38 micromoles/ml) were added, and samples were vortexed for
one minute.

After shaking overnight (Eberbach shaker) in a

dark room at room temperature , 5 mg proline (200 mg/ml
water) was added to each sample .

The tubes were again
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vortexed for one minute and then shaken for an additional
hour in the dark to eliminate unreacted Dans Cl.

Six ml of

toluerie was then added to each sample, and the samples were
vortexed for one minute, followed by centrifugation at 1500
rpm for 30

minute~.

Five ml of the organic extract contain-

ing the dansylated polyamines was transferred to Corex test
tubes and evaporated to dryness using a Buchler Rotary
Evapomix.

Any remaining liquid residue was evaporated in a

stream of nitrogen gas .

The residue was resuspended in 50

microliters of HPLC grade chloroform, and 20 microliters of
this sample was injected into the HPLC for analysis.
A Perkin Elmer Series 2 HPLC system incorporating a
fluorescence detector (Model 210-A) and a Rheodyne 7105
injection valve were used for the analysis.

Two HPLC

systems were employed during these studies.
Most of the separation of the dansylated derivatives
was achieved on a Perkin Elmer Silica B/5 (0.45 x 25 em)
column and a Silica A (0.26 x 25 em) precolumn.

Here samples

were separated with a solvent of chloroform:isopropanol
(75: 2) at a flow rate of 0 . 4 m. /min.

A second system em-

ployed two Silica B/5 (0.45 x 25 em) columns connected in
series with a mobile phase of chloroform:isopropanol (20:1)
at the same flow rate as above.

The chromatographic

elution patterns were recorded on an Omni-Scribe recorder
(Houston Instrument) set at 0.1 mv.

All HPLC solvents were

degassed before use with a Millipore filtering apparatus
(xxl504700 containing a FHUP 04700 filter).

Standard
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solutions containing 1-5 nanomoles of N - and N -acetylspermidine were analyzed concurrently with each series of
urine samples.
G. · Tdentifica·tion of N1 -Acety1spetmidine in Urine
Fractions were collected from the HPLC effluent of the
urine samples with a retention time similar to the standard
polyarnines.

The lag time between detection of a peak by the

detector of the fluorimeter and its elution were previously
quantified.

The eluate was evaporated to dryness.

The residue was resuspended in 50 microliters chloroform,
and 10 microliter fractions were spotted on TLC plates.
Silica gel plates (Silica gel 60, VVJR) were used throughout.
The plates were developed using one of the following solvent
systems:

chloroform:triethylamine (5:1), chloroform:isoprop-

anol (10:1), or benzene:methanol (9:1).
H.

Standard Calibration Curve

A standard curve which compared neak area and the concentration of N1 -acetylspermidine standard was prepared for
use in quantitation of urinary N1 -acetyls,permidine levels.
For urine analysis, standards ranging from 0.5-10 nanomoles
which covered the range of urinary N1 -acetylspermidine
encountered during the experiment, were dansylated and
analyzed by HPLC.

The area of the peaks

~1as

estimated by

the triangulation method (peak height multiplied by the
width of the peak at one half the height). Calculations of
N1 -acetylspermidine in the urine was derived by comparing
the area of the urine peak to the standard curve.

Since the
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urine samples and the N1 -acetylspermidine standards were
taken through identical procedures, it was not necessary to
correct for loss.

It was assumed that the loss from the

urine sample during the derivitazation and assay procedure
equalled the loss from the standards which were run in para llel with the ·urine samples.
I.

Determination of the Specificity and Percent Yield of
· the Dansylatioh Reaction

A solution containing tritium- labeled N1 -acetylspermidine (1 x 10 5 cpm) was dansylated as described above . For
determination of percent yield, 0.1 ml samples from the
aqueous or organic layer of the dansylation reaction were
transferred to counting vials containing 10 ml of scintillation fluid.

For the aqueous samples, 1 ml distilled water

was also added to enhance the miscibility of the sample.
In addition, 0.1 ml of the radiolabeled standard was added
directly to the scintillation vial to quantify the initial
radioactivity.
When the radiolabeled standard was separated by HPLC,
two minute fractions of the eluate were collected, and 0.1 ml
aliquots were measured for radioactivity.

The scintillation

cocktail contained 1.39 1 toluene, 0.660 1 Triton X-100,
7.32 g 2,5-diphenyloxazole (PPO), and 1.32 g 1,4-bis-2(5~phenyloxazoly)benzene

(POPOP).

Radioactivity was quanti-

fied using a Beckman CPM-100 scintillation spectrometer.
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J.

Creatinine Assay

A creatinine assay kit was purchased from Sigma (555-A).
Levels of creatinine in the urine samples were analyzed with
an alkaline picrate solution to form a colored complex which
was quantified by colorimetric spectrometry.

RESULTS
A.

Separation of the Monoacetylated Polyamine Standards
by HPLC

1
The elution pattern for the HPLC separation of N acetylspermidine, N8 -acetylspermidine, and acetylputrescine
is illustrated in Figure 2 .

Under similar HPLC conditions,

Abdel-Monem et al (29) observed a comparable elution
pattern of dan~ylated standards. In both studies didansylated N1 - acetylspermidine was initially eluted followed by
didansylated N8 -acetylspermidine, and then monodansylated
acetylputrescine .

Determination of retention times of

various concentrations of monoacetylated polyamines indicated reproducibility of this elution pattern .
are summarized in Table I .

These data

Monoacetylated polyamine levels

ranged from 0.1 to 10.0 nanomoles .

The data indicate

adequate separation and reproducibility of the dansylated
products.
B.

Identification and Quantification of the Standard N1 Acetylsperinidine Peak
The proposed N1 -acetylspermidine peak was idenitified by
20
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Table I

Retention Time and Peak Areaa of Monoacetylated Polyamine from HPLCb
Analysis

c
Retention time · (sec)

Peak Aread (mm 2 )

N1 -Acetylspermidine

N8-Acetylspermidine

Acetylputrescine

N1 -Acetylspermidine

Number of determinations

9

9

9

12

Range

1555-1645

1850-1930

4140-4235

12.25-20.0

1600 + 30

1890 + 24

4190 ±_ 33

14.84 + 2.44

Mean

+

~tandard

deviation

1
a Each peak area represents 1 nanomolar samples of N -acetylspermidine.
b HPLC analysis was performed under standard assay conditions. Analysis was performed
over a 2-3 day period.
c Solvent system:
chloroform:isopropanol (50:3)
d Solvent system:
chloroform:isopropanol (75:2)

[\)

w
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a combination of chromatographic and radioisotopic techniques .

There was a linear relationship between peak area and
the amount of standard N1 -acetylspermidine added (0 . 5-10

nanomoles), as is illustrated in Figure 3.

Regression

analysis was used to determine the best fitting line for the
data points, and a correlation coefficient of 0.9647 was
obtained for this

stand~rd

curve,

Though the line does not

pass through the origin, a linear relationship exists over
the range of values in the urine samples (0.85-4.1 nanomoles) .
Identification of the N1 -acetylspermidine peak was
confirmed by the standard HPLC analysis of a tritiumlabeled N1 -acetylspermidine sample (1 x 10 5 cpm.). Fractions
of the eluate from the radiolabeled standard were collected
and quantitated using liquid scintillation spectrometry.
As seen in Figures 4A and 4B, only the fraction of the
eluate that corresponded to the proposed N1 -acetylspermidine
peak was found to contain a large amount of radioactivity .
This data confirmed the identity of the peak as the
didansylated derivative of N1 -acetylspermidine.
Assay of a series of 1 nanomolar samples of N1 -acetylspermidine determined the reproducibility of the peak area.
This data is shown in Table I .

The samples analyzed were

derived from three separate dansylation reactions.

The peak

area showed sufficient reproducibility for HPLC analysis.
C.

Analysis of Recovery .and Specific=itY of the Dansylation
Procedure and Assay
Dansyl chloride reacts rapidly with free amine groups
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of polyamines as well as with other compounds which may be
present in urine (44).

Compounds such as free amino acids

may be partially fragmented during the dansylation reaction .
However, this does not generally occur in the case of the
amines (44) . In the present studies, radiolabeled N1 acetylspermidine was employed to measure the percentage of
N1 -acetylspermidine undergoing dansylation ,. and to determine
whether fragmentation of the dansylated polyamines could be
1
detected. A sample containing tritium-labeled N -acetylspermidine was carried through the standard dansylation and
extraction procedures with analysis of radioactivity performed throughout.
After the dansylation reaction, the dansylated polyamines were found in the organic layer of the reaction solution while unreacted acetylated polyamines remained in the
aqueous layer .

The organic layer contained 95.3% ± 1.3

(mean± 1 S.D . ) of the initial radioactivity, while only
3.3%

±

layer.

0.5 (mean

1 S.D.) was contained in the aqueous
Therefore over 95% of the radioactive N1 -acetyl±

spermidine standard reacted with the dansyl chloride.
Following evaporation of the organic layer, a fraction
was analyzed by HPLC.

Aliquots of the eluate were collected

during 2 minute intervals, and the radioactivity measured.
Only one radioactive peak was found (Figure 4B), which corresponds to the standard N1 -acetylspermidine peak. This
suggests that the acetylated polyamine was not degraded
during the dansylation reaction and assay procedure.
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When the radioactivity collected off the column was
pooled, only 60.3% ± 15.7 (mean± 1 S.D.) of the total
initial radioactivity was recovered.

This 60% recovery for

the entire assay procedure was assumed to be consistent for
both standard and urine samples.
The columns were flushed with methanol to determine
whether any radioactive derivatives remained bound to the
silica; no significant radioactivity was eluted.

Therefore,

the loss of product may not reflect retention on the HPLC
columns.

Since no significant loss occurred during the

dansylation reaction, and no discernable product remained on
the columns, the loss may be due to the evaporation step
just prior to HPLC analysis.

This is conjecture since per-

cent loss due to the evaporation step was not determined.
1
D. · · Identification of N -Acety1sp·e rm:idihe in Rat Urine
Analysis of urine samples produced peaks with retention
times similar to the standard N1 -acetylspermidine and N8 acetylspermidine (Figure 5) . In order to determine whether
N1 - and/or N8 -acetylspermidine were present in urine, a normal urine sample was compared to another urine sample
"spiked" with N1 - and N8 -acetylspermidine. As seen in
Figure 6, the two urine peaks which corresponded to the
standard N1 - and N8 -acetylspermidine were greatly enhanced.
A urine sample was separated by HPLC and the eluate
with a retention time equivalent to that of the N1 -acetylspermidine standard was collected for analysis by TLC.
Rf values obtained from the standard N1 -acetylspermidine

The
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and from the above sample were comparable in three solvent
systems (Table II).

Thus the TLC analysis, and the "spiked''
1
urine samples confirm the presence of N -acetylspermidine
in rat urine.
E.

Normal LeVels of N1 -Acety1sperrnidine in Rat Urine
1
Normal levels for urinary excretion of N -acetyl-

.spermidine were determined in twelve adult make rats.

These

results are shown in Table III, using the following three
methods for expressing the quantities excreted:
centration in urine, (ii)

(i)

con-

concentration in urine normalized

for creatinine excretion, and (iii)

24 hour urine output.

Since most of the literature expresses urinary polyamine
levels as the total amount of polyamines excreted in 24
hours (21, 33, 43), this mode of reporting polyamine excretion will be emphasized in the present paper.

Russell,

citing clinical evidence (24), suggested that urinary polyamine levels are more reliably expressed in terms of creatinine excretion.

Shipe (45) has observed that many variables

which affect renal function can alter the above measurements.
Therefore, data expressed as concentration would be more
accurate.

Consequently alternative methods which describe

polyamine excretion will be reported.
exhibit comparable variability.

The three methods

Pearson's coefficient of

variation (V) (46) for each is similar, but the expression
of polyamine excretion as a function of 24 hour urinary
volume shows the least variation (V = 26%) .

Table II

Solvent
System b

Thin-Layer Chromatographic Analysis
Puriried by HPLCa

or

Acetylpolyamines and Urine Peaks

Rr values
N1 -Acetylspermidine
Sfaridard
Puriried
urine peak

I

0.59

0.58

II

0.40

0.39

III

0.19

0.19

NS-Acetylspermidine
Standard
Purified
urine peak

0.35

0.35

aHPLC analysis was perrormed under standard assay conditions.
bsolvent I: chlorororm:isopropanol (10:1); Solvent II: chlorororm:triethylamine (5:1);
Solvent III: benzene:methanol (9:1).

w
0\

Table III

Normal Values of N1 -Acetylspermidine in Rat Urinea

N 1 ~Ac~tylsp~~midihe

Normal value
Coefficient of
. t.1on, %c
var1a
_o

N

Concentration
in urine
(nmoles/mll

Quantitiy excreted
in 24 hours
(nmoles/24 hrs2

Concentration normalized
for creatinine
(nmoles/ mg creatinine)

12

~24.4' + 37.lb

803.1' + 208.9b

127.3

~9.82

26.01

34.25

±. 43.6b

aHPLC analysis was performed under standard conditions.
bMean + 1 S.D.
ccoefficient of variation = 100 S.D./mean.

w
--J
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Most assays which quantitate acetylpolyamines in urine
deal with human studies .

The variability seen in the

present animal study is comparable to that reported by other
researchers who have measured urinary excretion of acetylpolyamines as indicated by the calculation of Pearson's
coefficient of variation (V) . Seiler and KnO'Hgen (43) reported the excretion of N1 -acetylspermidine in human urine
(micromoles/24 hrs) as 5 . 3

±

yields a calculated V of 34%.

1.8 (mean

±

1 S.D.).

This

Seiler's assay contained an

additional purification step which may have increased the
variability.

Seiler noted a large variation between sub-

jects - probably because some subjects were "high" or "low"
excreters of polyamines. Abdel-Monem et al (33) also
reported normal N1 -acetylsperrnidine levels in human urine.
These workers found the mean excretion (micromoles/24 hrs)
to be 2.9

±

1.8 with a calculated V of 62%.

Since great

variability can exist between subjects, a high standard
deviation, and hence a high V, is expected for an assay
dealing with urinary excretion of polyamines.
Normal levels of free polyamines have been described
in rats.

Andersson and co-workers (21) reported the average

spermidine excretion in nonpregnant rats.

Their data for

these animals exhibited only a slight spread (220-240
nanomoles/24 hrs).

However these animals demonstrated a

high day-to-day variation (V = 20-40%).

In a practical

sense, this wide variation in polyamine excretion over the
course of an experiment means that real differences between
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Table IV

Effect of Castration on the Concentration of
Creatinine Excreted in Rat Urine

Operation

N

Urine creatinine levels (rng/ml ;a
Pre-operation

14 Days after operation

Sham

6

0. 94" + 0.33

1.16 -+ 0.42

Castrated

6"

1.26 -+ 0.59

1.09 -+ 0.29

a

Mean+ 1 S.D.
All samples w·e re run in duplicate.
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Tahle y

Effect of Castration on Rat Daily Urine Volume

Operation

N

Urine volume (ml/24 hrs)a
Pre-operation

14 Da:vs after operation

Sham

6

6.92+1.42

9.37!_1.32 b

Castrated

6

6.53+1.91

9.28+2.65

aMean + 1 S.D.
bsignificantly different from pre-operation value at P(0.02.
Studentts t test was used to test for ~ignificance b~tween
groups.
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Table VI

The Effect of Castration on the Total N1 Acetylspermidine Excretion per Day in Ratsa

N1 -Acetylspermidine excretion (nmoles/24 hrs)b
Operation

N

Pre-operation

14 Days after
operation

Percent
change c

Sham

6

788. 8~:_212. 2

1232.8+193.2

+62.7

Castrated

6

817.4+224.6

1019.5+308.1

+27.0

aHPLC analysis was performed under standard assay conditions.
bMean + 1 S.D.
cFor calculation of percent change, the value for each
animal was compared to the pre-operation value for the
same animal.
All urine samples were analyzed in duplicate.
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Tahl e. VII

The Effec t of Castration on the Concentration
of Nl - Acetylspermidine Excreted in Rat Urine
b
N1 ... Acetyls·permidine Cnmoles/ml urine 2

O~eration

' N

Pre..:operation

14 Days after
operation

Percent
change c

Sham

6

118.1 + 40 . 3

134.8 + 32.6

+22.2

Castrated

6

130.8 + 3'6.2

112.6 + 34.0

-12.2

~HPLC analysis was performed under standard assay conditions.

Mean + 1 S.D.
cFor calculation of percent change, the value for each
animal was compared to the pre-operation value for the
same animals.

All urine samples were analyzed in duplicate.
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The Effects of Ca.stratlon on the Excretion
of Nl-Acetyls.permidine as a. ;Function of
Creatinine Excretiona

Table VIII

N1 ..-Acetylspermid;i:ne (Nmoles/.m.g creatinine) b
Operation

N

Pre_:operati'on

14 Days after
operation

Percentc
change

Sham

6

134.Q + 51.2

124.4 + 44.4

-1.3

Ca.strated

6

120.6 + 38.1

107.2 + 31.4

-7.2

aHPLC analys·is was performed under standard assay conditions.
bMean + 1 S.D.
CFor calculation of percent change, the value for each
animal was compared to the pre-operation value for the
s·ame animal.
All urine samples were analyzed in duplicate.
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experimental groups can be difficult to prove statistically.
The data reported in the present study also exhibited a
large variation within the group (V = 26-34%), depending on
the method of expressing the data.

Still the variability of

this assay is similar if not less than other comparable
assays.

F.

Effect of Gastratioh on the Excretion of N1 -Acetylspermidine
This study compared the urinary excretion of N1 -acetyl-

spermidine of six castrated rats to that of six sham operated
controls.

During the 14 day period after castration,

urinary creatinine concentration did not change significantly
(Table IV).

Although urinary output apparently increased

for both the sham and castrated groups (Table V), no significant difference in the urinary output was found between
groups using the

Student'~!

test.

Since daily urinary volume increased markedly over the
14 day experimental period, it was not surprising that the
mean excretion of N1 -acetylspermidine per 24 hours increased
in both groups (Table VI).

Daily excretion of N1 -acetyl-

spermidine in the castrated group (1019.5 nmoles/24 hrs) did
not increase as much as that in the sham operation group
(1232.8 nmoles/24 hrs), and this difference was not significantly different.
Urinary excretion of polyamines expressed as a function
of concentration and creatinine excretion are presented in
Tables VIII and VIII.

As seen in Table VII, castration appeared to decrease the concentration of N1 -acetylspermidine

45

excreted in the urine.

When each animal served as its own

control, the sham operated group showed an increase of 22%
while the castrated group exhibited a decrease of 12% in the
excretion of N1 - acetylspermidine . No significant difference
was found between groups because the variance within each
group was high .

Similar results were seen with the creati -

nine data (Table VIII) .
In summary, urinary N1 -acetylspermidine levels in the
castrated animals appeared to be lower than in the sham
group.

Yet this decrease was not significant for any method

of data presentation.
G.

The Effect of Testosterone Administration in the Excre. tion: of N1 - Acetylspermidine in Castrated Rats

Three groups of six animals were studied to determine
the effects of testosterone on the excretion of N1 -acetylspermidine in castrated rats.

Two groups consisted of

castrated animals - one group received testosterone, and the
other received vehicle.

The third group consisted of sham

operated animals receiving just vehicle .

One animal in the

castrated group receiving testosterone was not used since
blood was found in the u<rine.

During the 14 days of testos-

terone administration, the daily ur i nary volume, as well as
the concentration of creatinine excreted in the urine, did
not change significantly (Tables IX and X) .
The effect of testosterone on the excretion of N1 acetylspermidine in castrated animals is presented in Tables
XI, XII and XIII.

The first 24 hours of urine collection
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Table I X

Effect of Testosterone Therapy on the 24 Hour
Urinary Output in Castrated Rats

Urine volume (ml/24 hrs)a
Operation/ Therapy

N
Day 1

b

Day

T

Day 14

Sham/Vehicle

6

2.97:!:_0.81

12.58:!:_3.46

10.83+1.59

Castrated/Vehicle

6

9.28~1.58

11.57:!:_1.87

9.80+2.13

Castrated/Testosterone 5

9.52+2.09

11.74~1.90

11.52+2.07

a

Mean+ 1 S.D.
bTherapy was initiated during final 8 hours of urine
collection.
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Table X

Effect of Testosterone Therapy on the
Concentration of Creatinine Excreted in the
Urine of Castrated Rats

Urine creatinine levels (mg/rnl) a
Operation/Therapy

N

Day 1

b

Day 7

Day 14

Sham/Vehicle

6

]_,65+0.28

1.54+0.20

1.54+0.39

Castrated/Vehicle

6

]_. 48+0. 58

1.24+0.16

1.26+0.16

Castrated/Testosterone 5

]_. 64±_0. 87

1.46+0.34

' 1.30+0.22

a Me an + 1 S . D .
bTherapy was· initiated during final 8 hours of urine
collection
All samples were run in duplicate

Table XI

1

Effect of Testosterone Therapy in Castrated Rats on the Total N Acetylspermidine Excretion per Daya
1
Nmoles N -acetylspermidine/24 hrsb (percent changec}

Operation/Therapy

N
Day ld ·

Day

Sham/Vehicle

6

1482.4+328.1

Castrated/Vehicle

6

1171.4~187

Castrated/Testosterone

5

1386.1+226.1

.6

7

Day 14

---1297.6~443.5

1290.6~277.2

(-12.3)

(+17.1)

1016.3+471.3 (- 7.0)

1640.2+397.4 (+21.2)

1290.1+625.8 (- 8.6)

a

HPLC analysis was performed under standard assay conditions. All samples were
banalyzed in. duplicate.
Mean+ 1 S.D.
cFor calculation of percent change, the value for each animal was compared to the value
dfor the same animal on Day 1.
.
Therapy was initiated during the final 8 hours of urine collection.

~
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Table XII

1
Effect of Testosterone Therapy in Castrated Rats on the Concentration of N Acetylspermidine Excreted in Urinea

1
Nmoles N -Acetylspermidine /ml urineb (percent changec)
Operation/Therapy

N
Day 1d

Day 14

Day 7

~----

---

Sham/Vehicle

6

142.2±_33.3

Castrated/Vehicle

6

127 .9±_20 .0

110.0±_25.1 (-10.2)

100.9±_28.3 (-20.0)

Castrated/Testosterone

5

148.6±_27.6

139.3±_23.7 (- 5 .6)

111.6±_45.6 (-26.6)

122.4±_37.5 (-17.6)

a

HPLC analysis was performed under standard assay conditi9ns. All samples were
banalyzed in duplicate.
Mean + 1 S.D.
CFor calculation of percent change, the value for each animal was compared to the value
for the same animal on Day 1.
dTherapy was initiated during the final 8 hours of urine collection.

4:::"
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Table XIII

1
Effect of Testosterone Therapy in Castrated Rats on the Excretion of N Acetylspermidine as a Function of Creatinine Excretiona

Nmoles N1 -acetylspermidine/mg creatinineb (percent changec}
Operation/Therapy

-N
Day 1 d

Sham/Vehicle

6

92.0 + 21.0

Castrated/Vehicle

6

92.0 + 20.3

Castrated/Testosterone

5

104 4
0

t 37 .l

Day 14

Day 7

89.3

---

80.2 + 18.8 (-10.4)

t 22.8 (+4.0)

80.3 + 19.9 (- 3.7)

96.2 t

7. 7 (+3. 5)

83.9

t 22.3 (- 5.9)

aHPLC analysis was performed under standard assay conditions. All samples were
banalyzed in duplicate.
Mean + 1 S.D.
cFor calculation of percent change, the value for each animal was compared to th.e value
for the same animal on Day l.
dTherapy was initiated during the final 8 hours of urine collection.

Vl
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represents only 8 hours of testosterone therapy. As seen in
1
Table XI, initially the daily N -acetylspermidine excretion
of the castrated group injected with testosterone (1386.1
nmoles/24 hrs) was greater than the castrated group which
received vehicle (1171.4 nmoles/24 hrs).

This difference

remained throughout the experiment, and by day 14 the daily
excretion of N1 -acetylspermidine in the testosterone group
was very similar to the sham group which received just
vehicle.

Throughout this experiment no significant differ-

ence could be detected between the three groups.
The concentration of N1 -acetylspermidine excreted in
the urine was very similar to the sham operated group after
one day of testosterone therapy (Table XII). When N1 acetylspermidine excretion was expressed as a function of
creatinine excretion, the testosterone group consistently
exhibited higher values than all other groups (Table XIII).
In summary, no significant differences were found among
the groups studied whether the values were reported as
daily excretion, concentration, or normalized for creatinine excretion.

However, several trends appeared.

The

testosterone treated castrated group showed an increase in
the excretion of N1 -acetylspermidine when compared to the
castrated group which received only vehicle. The levels of
1
N -acetylspermidine excretion in the testosterone treated
animals approached or exceeded that of the sham animals.
Just eight hours of testosterone therapy increased the excre1
tion of N -acetylspermidine in the castrated animals compared
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to the castrated group receiving vehicle.

Since no measure-

ments were taken the day before the testosterone administration, . it is difficult to interpret this finding .
H. · Effect of Gast·r ation and Testost·erone Replacement on Body
and Kidney vleight.
Animal weights changed markedly in response to castration (Table XIV).

Two weeks after castration, both castrated

groups showed a significant decrease in body weight of
approximately 15% when compared to the sham operated group .
Testosterone was then administered to one castrated group
while the other groups received vehicle.

At this time both

castrated groups weighed significantly less than the sham
operated group.
During the second experimental period, the castrated
group which received just vehicle weighed significantly less
than the sham group which received vehicle.

However after

7 or 14 days of testosterone therapy, the testosterone
treated castrated group did not weigh significantly less
than the sham group.

Therefore testosterone increased the

body weight of the castrated animals markedly relative to
the castrated group given vehicle .
The kidney weights of the animals appear to respond
directly to the testosterone administration (Table XV) .
After 14 days of testosterone therapy, the animals were
sacrificed and kidney weights were measured.

Testosterone

no.t only increased the kidney weight of the castrated
animals above the castrated animals receiving vehicle alone

Table XIV

Effects of Castration and Testosterone Replacement Therapy on Body Weight
in Rats
Weight (grams)a

Operation/ Therapy

N
Days after operation without
therapy

Days on therapy

0

7

14

lb

7

14

Sham/ Vehicle

6

183+11

239+ 8

280+14

337:!:_18

34 7:!:_2 8

387:!:_26

Castrated / Vehicle

6

188+10

211+10e

239+12e

292:!=_12e

304+19d

323+24c

Castrated/ Testosterone

5

178+13

206+ 8e

239+ 7c

299+18c

333+19

3 56+23

a
bMean t 1 S .D.
Therapy was initiated during the
~S~gn~f~cantly d~fferent fro~ the
Slgnlflcantly dlfferent from the
eSignificantly different from the
to test for significance between

final 8 hours of urine collection .
Sham/Veh~cle group at ~0.01.
Sham/Vehlcle group at P' 0.02 .
Sham/Vehicle group at P <0.001. Student's t
groups.

test was used

Vl
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Table XV

Kidney Weight of Animals After Final Urine
Collection
Kidney Weight (grams)a

Operation/Therapy

N

Sham/Vehicle

6

2.26+0.35

"0. 01

Castrated/Vehicle

6

2. 092:_0. 23

< 0. 001

Castrated/Testosterone

5

2,8l+0.23

aMean + l S.D.
bstudent's t test was used to test for significance between
groups.
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(t = 4.667, P<O.OOl), but also increased the average kidney
weight above the level of the noncastrated animals given
vehicle (t = 3.181, P<O.Ol).

The increase in kidney weight

in response to testos.terone administration is in agreement
with the work by Kochakian (47) .

This suggests that the

testosterone therapy employed in the present study was
effective.

DISCUSSION
The assay employed in this study was a specific and
1
sensitive HPLC technique for the determination of N - acetylspermidine levels in urine. The urinary N1 -acetylspermidine
der i vative was adequately separated from the surrounding
peaks, thus allowing satisfactory quantification to be
achieved.

The assay system exhibited a range of linearity

from 0 . 1 to 10 nmoles which encompassed the physiological
variability observed for urinary N1 -acetylspermidine levels
(0.85-4.1 nmoles).
One criticism of this study may be that the i dentity of
the urinary N1 -acetylspermidine was not verified by specific
methods such as mass spectral analysis. However the occurrence of N1 -acetylsperrnidine in urine has been reported previously by Noto (28), and in the present study both TLC and
HPLC analysis were used to confirm the identity of the
N1 -acetylspermidine in rat urine. In addition a radiolabeled
standard was used for comparison with the proposed N1 -acetyl spermidine peak.

It may be argued that since the tritium
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label is on the acetyl group on t h e N1 -acety 1 sperm~"d"~ne, th e
1
radioactivity which corresponded to the proposed N -acetyl spermidine peak may actually be an acetyl fragment of the
N1 - acetylspermidine standard. Nevertheless this peak exhibited a linear relationship between peak area and quantity
of N1 -acetylspermidine standard . Therefore this peak
1

whether a fragment or not reflected the quantity of N -acetyl spermidine in the sample.
Urinary N1 -acetylspermidine levels are measured by comparing peak area to the standard curve .

This assumes that

the loss during -the assay work-up is similar to the loss
incurred during construction of the standard curve .

An

obvious improvement for quantitation would be the addition
of an internal standard compound to the urine samples prior
to the work-up, but no appropriate compound could be identified.
For acetylpolyamine analysis, this assay has some disadvantages when compared to other assay systems. This
assay does not adequately quantitate urinary N8 - acetylspermidine or acetylputrescine unlike the assays of Seiler and
KnC>dgen (43-) and Abdel-Monem and Ohno (33). Urinary
N8 -acetylspermidine was masked due to elution of a broad
complex peak, thus it could not be quantitated. The presence
of N8 -acetylspermidine in this complex peak was confirmed by
TLC, but only using a single solvent system.

A peak was

eluted with a retention time exceeding 90 minutes which
corresponded to the standard acetylputrescine peak.

58

Therefore quantitation of acetylputrescine was not practical
utilizing this isocratic solvent system of chloroform:
isopropanol (75 : 2) .

Perhaps this assay in conjunction with

a gradient solvent system would facilitate analysis of
acetylputrescine.
Unlike this assay both the assay system of Abdel-Monem
and Ohno (33) and Seiler and Knodgen (43) contain a lengthy
clean-up procedure prior to analysis which allowed for
adequate differentiation between N1 - and N8 - acetylspermidine.
Both groups of researchers report a reasonable percent yield
even after a purification step .

Seiler and Knodgen (43) ob-

served that the percent yield for the dansylation reaction
was high which agrees with the results obtained in the
present study (<95% recovery).

After analysis by TLC their

percent recovery was greater than 90%.

Abdel-Monem's group

reported a 73% recovery for their HPLC analysis which included a prior TLC separation step (33) .

The assay presented

here yielded a percent recovery of approximately 60%.

Re-

covery of the radiolabeled standards at various steps of the
assay indicate that the most likely source of loss was the
evaporation step prior to HPLC analysis.
A pre-analysis purification step may not only increase
the resolution of the assay, but it might decrease the amount
of baseline fluorescence observed during the elution of the
by-produ~ts

of the dansylation reaction.

This background

fluorescence may have artificially increased the peak height
of N1 -acetylspermidine eluted, but peak area measurements
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compensated for the high background fluorescence.

Since

these undesired dansylated products elute very early, a pre separation step utilizing a nonpolar solvent might be
reasonable .
Urinary excretion of polyamines may be expressed by
three methods: concentration of urine, concentration
adjusted for creatinine excretion, and 24 hour urinary output.

When polyamine excretion is related to concentration,

this correlates excretion of the polyamine to urine volume.
Urine volume is a highly variable parameter, so perhaps
polyamine excretion should be associated with a more stable
function .
Russell and Russell (24) reported that urinary polyamine
excretion in patients showed less day to day variability if
normalized for creatinine excretion.

Creatinine excretion

normally remains very stable in an individual as long as
glomerular filtration rate remains constant .

However since

creatinine reflects muscle mass, a study which manipulates
anabolic steroid levels may change creatinine levels.

There -

fore expression of polyamine excretion as a function of
creatinine excretion may not be valid for this study.
Polyamine excretion as a function of 24 hour urine output relates excretion to time which is obviously constant
for all animals.

Polyamine excretion is most frequently

expressed in this manner in the literature .

Shipe (45) has

noted that changes in renal function can alter this data.
So changes in polyamine excretion/24 hr may reflect either
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a real change in the amount of polyamines or changes in renal
function.

Therefore in order to differentiate between the

two, other measurements of renal function should be per formed simultaneously with polyamine measurements.
The values for N1 - acetylspermidine presented here represent the first reported normal levels for this compound in
rat urine . Approximately 800 nmoles of N1 -acetylspermidine
was excreted per day.

Traditionally urine has been hydro -

lyzed prior to analysis to free spermidine from its acidlabile conjugates such as N1 and N8 -acetylspermidine (24).
Andersson et al (21) reported normal levels of free spermidine in rat urine as approximately 220 nmoles/24 hrs.

Com-

parison of this work to the present study are difficult due
to differences in the animal sex, strain, and diet plus
differences in urine sample work-up.

They did not subject

the urine to heated acid hydrolysis, so perhaps they measured
predominately free spermidine which in humans comprises about .
10% of the total spermidine excreted in urine (43).

This

seems reasonable since when they did hydrolyze the urine
samples, free spermidine levels doubled.

Since the amount

of free spermidine is expected to be less than the acetylated levels as indicated in human studies, the values obtained in the two studies seem comparable.
Using this assay, N8 -acetylspermidine was identified in
rat urine, but not quantified. It did appear that the
amount of N8 -acetyl spermidine 'li7as less than the level of
N1 -acetylspermidine since the complex peak which contained
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1
the N8 - acetylspermidine was smaller than the urinary N acetylspermidine peak. It can be argued that the peak area
of the broader N8 -acetylspermidine complex may be equal to
1
8
the N1 -acetylspermidine peak. However since N - and N acetylspermidine are both didansylated compounds, hence have
a similar fluorescent nature and are eluted in proximity to
each other, equal concentrations of the two compounds should
produce similar shaped peaks as was seen with equal molar
concentrations of N1 - and N8 -acetylspermidine standards . In
urine samples, the N1 -acetylspermidine peak wa$ comparable
to that of the standards, but the N8 -acetylspermidine peak
was not. Thus N8 - acetylspermidine appears to be excreted in
lower quantities than N1 - acetylspermidine in rats. In human
studies, N1 - and N8 - acetylspermidine are excreted in similar
molar quantities . The ratio of N1 -acetylspermidine to N8 acetylspermidine excreted in urine ranges from 0.94 to 1.21
(33' 34) .

Though no statistically significant differences could be
noted in urinary excretion of N1 -acetylspermidine in response to castration and testosterone replacement therapy,
several trends can be pointed out.

TNhile both the sham

operated group and the castrated animals displayed an increase in the excretion of N1 -acetylspermidine 14 days after
the operation, the castrated group exhibited less augmentation.

Castration leads to a decrease in ODC activity and

putrescine content in rat and mouse kidney (19, 48), so the
increase in N1 -acetylspermidine excretion does not reflect
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the theoretical decrease in kidney predicted for polyamines
following castration.

Shrock et al (49) noted that ODC

activity, the rate limiting enzyme in polyamine synthesis,
increased markedly just after sham operations . Therefore
the increase in N1 -acetylspermidine may be due to increased
intracellular polyamines due to induction of ODC activity,
but this response may be attenuated by castration.
An alternative explanation may be that in both groups,
daily urine output increased markedly during this experimental period, and this could explain the increased N1 acetylspermidine excretion .

Since animals were housed in

metabolism cages three days prior to the first urine collection, acclimation should not have been a factor .

In order

to discover whether the operation itself may have been
responsible for the change in urine output, a group of non operated control animals should have also been studied .
Testosterone administration to castrated rats increased
1
N -acetylspermidine excretion 20% per day, but this increase
was not found to be statistically significant.

Testosterone

has been reported to increase renal blood flow in mice (50),
which may account for the elevation of urinary N1 -acetylspermidine seen in castrated rats after testosterone therapy
when compared to castrated rats given vehicle.

Still

Henningsson et al (19) reported that nandrolene treatment increased the excretion of spermidine and putrescine by four
fold and 20 fold, respectively, in castrated mice.

They

measured levels of free spermidine in urine without previous
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heated acid hydrolysis . Therefore it may be possible that
nandrolene only increased free spermidine excretion, not the
excretion of the acetylated derivatives.

Other explana-

tions are also possible including species differences .
Castration did not produce a significant decrease in the
urinary N1 -acetylspermidine excretion in the present study,
so it is not surprising that testosterone would not increase
this polyamine level in the urine of castrated animals .
Also there is the possibility that nandrolene may increase
polyamine excretion dramatically due to its higher anabolic
to androgenic ratio relative to testosterone (19) .
The origin of urinary acetylated polyamines still has
not been elucidated.
posed.

However several sources have been pro Smith et al (51) have reported that N1 -acetylspermi -

--

dine occurs in only very small quantities in human serum
compared to urine.

This suggests that the acetylation of

polyamines which appear in urine occurs via a renal rather
than by a hepatic or some other route.

The kidney chromatin

fraction possesses acetylating activity as does the renal
microsomal fraction (52) .

Therefore the kidney may either

be a site for acetylating serum polyamines for excretion, o'r
perhaps the kidney may serve to concentrate serum acetylated
polyamines in urine via a transport mechanism.
Since renal tissue is a target for testosterone, it may
be possible that changes in polyamine levels in the kidney
may be directly reflected in the urine.

Castration leads to

an involution of the kidney in mice (47), and after
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testosterone administration an increase in kidney weight due
to hypertrophy is seen.

This increase in weight reflects

an increased activity in ODC which stimulates production of
the precursors for acetylated polyamines (18).

In addition

increased renal RNA and protein content are noted in response
to testosterone administration (19) .

Since renal protein

content increased, changes in other enzymes such as acetyltransferases in addition to ODC might be expected .
Blankenship (52) has observed that the renal hypertrophy
induced by the concurrent administration of growth hormone
and adrenocorticotropic hormone is accompanied by an increase in polyamine acetyltransferase activity in rat renal
chromatin fraction.

This leads to the speculation that tes -

tosterone may increase acetyltransferase activity in renal
tissue due to its anabolic nature.

Thus the increase in

polyamine production and acetyltransferase activity may be
reflected in increased acetylated polyamine excretion.

The

proportion of urinary acetylated polyamines from renal and
nonrenal tissue remains unknown.
The high variation in the excretion of N1 -acetylspermidine made differences between treatments difficult to prove
statistically.

Variation was great not only between test

groups, but even when animals were used as their own controls.
Studies on the excretion of the parent polyamine in urine
shmv similar results (21, 33, 43).

Only when differences

between groups are large, such as in the nandrolene study

(I9), can statistical differences become apparent.
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Therefore subtle changes in urine polyamine excretion may be
masked by the profound variation in polyamine excretion due
to normal physiological variation (53) .

If the number of

animals per group were to be increased, then these changes
may be documented.
1
This study suggests a real decrease in excretion of N acetylsperrn'i dine due to castration compared to the sham
operated group, followed by a small recovery after testosterone therapy was initiated.

These trends are in agreement

with the hypothesis that urinary excretion of acetylated
polyamines may reflect the anabolic state of the animals.
However further studies on the effects of these and other
anabolic stimuli on the excretion of acetylated polyamines
and on the activity of polyamine metabolizing and acetylat ing enzymes are required to eluc.idate the significance of
these observations .

CONCLUSIONS

The HPLC as-say s·ys·tem which utilized the dansylation
reaction quantitated nanomolar levels of N1 -acetylspermidine
in urine

with~arked

sensitivity and reproducibility,

The normal level of N1 -acetylspermidine excreted in
rat urine was found to he approximately SQQ nanomoles per
day. In addition, both N8-acetylspermidine and acetylputrescine were detected, but not quantitated.

No statiatically significant difference could be
detected in urinary excretion of N1 -acetylspermidine between
castrated animals·, castrated animals receiving testosterone,
and sham-operated animals. These data suggest that castrati.on and tes·tosterone replacement th.e rapy do not change
the urinary excretion of N1 -acetylspermidine dramatically.
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